Patent: 9,434,785
✉ Email this page to a colleague
Summary for Patent: 9,434,785
Title: | Anti-human OX40L antibodies and methods of treating graft versus host disease with the same |
Abstract: | The present invention relates to anti-human OX40L antibodies, new medical uses and methods. |
Inventor(s): | Bland-Ward; Philip (Cambridge, GB), Campbell; Jamie (Cambridge, GB), Holmes; Steve (Cambridge, GB), Kirby; Ian (Cambridge, GB), Kosmac; Miha (Cambridge, GB), Kean; Leslie Susan (Seattle, WA), Tkachev; Victor (Seattle, WA) |
Assignee: | Kymab Limited (Cambridge, GB) |
Application Number: | 14/935,937 |
Patent Claims: | see list of patent claims |
Details for Patent 9,434,785
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Genentech, Inc. | RITUXAN | rituximab | Injection | 103705 | 11/26/1997 | ⤷ Try a Trial | 2035-09-09 |
Idec Pharmaceuticals Corp. | RITUXAN | rituximab | Injection | 103737 | 02/19/2002 | ⤷ Try a Trial | 2035-09-09 |
Hoffmann-la Roche Inc. | ZENAPAX | daclizumab | Injection | 103749 | 12/10/1997 | ⤷ Try a Trial | 2035-09-09 |
Janssen Biotech, Inc. | REMICADE | infliximab | For Injection | 103772 | 08/24/1998 | ⤷ Try a Trial | 2035-09-09 |
Immunex Corporation | ENBREL | etanercept | For Injection | 103795 | 11/02/1998 | ⤷ Try a Trial | 2035-09-09 |
Immunex Corporation | ENBREL | etanercept | For Injection | 103795 | 05/27/1999 | ⤷ Try a Trial | 2035-09-09 |
Immunex Corporation | ENBREL | etanercept | Injection | 103795 | 09/27/2004 | ⤷ Try a Trial | 2035-09-09 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |